Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Clyne

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Blood|February 1, 1983
The origin of cerebrospinal fluid procoagulant activityD M Komp, L P Clyne, E Sullivan
Thrombosis and Haemostasis|July 29, 1984
Correction of clotting factor "deficiencies" in plasma from patients with lupus-like anticoagulantsL P Clyne, C L Honig, N Dainiak
Annals of Internal Medicine|October 1, 1972
Circulating anticoagulants against factors IX and XI in systemic lupus erythematosusO Castro, L R Farber, L P Clyne
Thrombosis Research|June 1, 1980
In vitro correction of anticoagulant activity and specific clotting factor assays in SLEL P Clyne, N Dainiak, R Hoffman, et al.
Thrombosis and Haemostasis|October 5, 1992
A high titre "spontaneous" porcine FVIII inhibitorL P Clyne, A Levy, S Stein, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
Procainamide-induced circulating anticoagulants in a congenitally-deficient factor XI patientL P Clyne, L R Farber, R L Chopyk
Invertebrate Neuroscience : IN|October 23, 1998
Odorant response of individual sensilla on the Drosophila antennaP Clyne, A Grant, R O'Connell, et al.
American Journal of Hematology|December 1, 1987
Acquired factor XI inhibitors in congenitally deficient patientsS F Schnall, T P Duffy, L P Clyne
Arthritis and Rheumatism|October 1, 1979
A circulating anticoagulant directed against factor XIa in systemic lupus erythematosusC A DiSabatino, L P Clyne, S E Malawista
Thrombosis and Haemostasis|March 1, 1994
Coagulopathy caused by intrauterine dextranP McPhedran, D B Seifer, L P Clyne, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Blood|February 1, 1983
The origin of cerebrospinal fluid procoagulant activityD M Komp, L P Clyne, E Sullivan
Thrombosis and Haemostasis|July 29, 1984
Correction of clotting factor "deficiencies" in plasma from patients with lupus-like anticoagulantsL P Clyne, C L Honig, N Dainiak
Annals of Internal Medicine|October 1, 1972
Circulating anticoagulants against factors IX and XI in systemic lupus erythematosusO Castro, L R Farber, L P Clyne
Thrombosis Research|June 1, 1980
In vitro correction of anticoagulant activity and specific clotting factor assays in SLEL P Clyne, N Dainiak, R Hoffman, et al.
Thrombosis and Haemostasis|October 5, 1992
A high titre "spontaneous" porcine FVIII inhibitorL P Clyne, A Levy, S Stein, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
Procainamide-induced circulating anticoagulants in a congenitally-deficient factor XI patientL P Clyne, L R Farber, R L Chopyk
Invertebrate Neuroscience : IN|October 23, 1998
Odorant response of individual sensilla on the Drosophila antennaP Clyne, A Grant, R O'Connell, et al.
American Journal of Hematology|December 1, 1987
Acquired factor XI inhibitors in congenitally deficient patientsS F Schnall, T P Duffy, L P Clyne
Arthritis and Rheumatism|October 1, 1979
A circulating anticoagulant directed against factor XIa in systemic lupus erythematosusC A DiSabatino, L P Clyne, S E Malawista
Thrombosis and Haemostasis|March 1, 1994
Coagulopathy caused by intrauterine dextranP McPhedran, D B Seifer, L P Clyne, et al.
Pageof 4